Back to UBS Group AG UBS Group AG

QNRXQNRX
Showing 8 of 18 quarters

Position history for UBS Group AGUBS Group AG's holdings in QUOIN PHARMACEUTICALS LTD

UBS Group AG holds 2,512 shares of QNRX (QUOIN PHARMACEUTICALS LTD), worth $16,579 as of 2026-Q1. The position was increased (+147x shares).

Current Value

$16,579

Current Shares

2,512

Total Value Change

+$13,042

Total Shares Change

-3,585

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2,512
+147x
$16,5790.0%$8.74
20
2025-Q4
Increased
17
+1600.0%
$2450.0%$13.50
12
2025-Q3
Decreased
1
-99.2%
$70.0%$7.04
0
2025-Q2
Decreased
130
-99.9%
$1,2000.0%$9.27
0
2025-Q1
Increased
219,295
+4494.5%
$49,1220.0%$8.47
22
2024-Q4
Decreased
4,773
-79.1%
$3,1070.0%$24.40
0
2024-Q3
Increased
22,821
+274.3%
$11,2500.0%$17.99
19
2024-Q2
Increased
6,097
+19.4%
$3,5370.0%$20.30
11

Other major holders of QNRX: Woodline Partners LP, Aberdeen Group plc, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used